Petros Kampanis1, Loretta Ford, Jonathan Berg. 1. Department of Clinical Biochemistry, City Hospital, Dudley Road, Birmingham B18 7QH, UK. Petros.Kampanis@swbh.nhs.uk
Abstract
BACKGROUND: Human faecal elastase-1 (FE-1) is an established biochemical test for the investigation of pancreatic exocrine insufficiency. Conventional extraction methods for FE-1 analysis can give false-positive results with watery stools. This is a major limitation as patients investigated for pancreatic disease commonly produce such stools. We have developed an improved FE-1 test that overcomes water interference by measuring the enzyme in dried faeces. METHODS: A novel collection device for FE-1 analysis that involves drying and weighing the stool sample was developed in our laboratory and compared with a conventional wet method, E1 Quick-Prep (Schebo, Biotech AG, Germany). The concentration of faecal FE-1 was determined using a commercially available enzyme-linked immunosorbent assay method (Schebo). RESULTS: FE-1 values obtained using the new dry extraction procedure (mean 1777 microg/g dry stool) were higher when compared with the conventional wet analysis (mean 402 microg/g stool). A 1:2 dilution in water, mimicking a loose stool, was found to affect FE-1 results obtained using the conventional wet extraction procedure. The new dry extraction method gave consistent results when water content was varied in the original stool sample. CONCLUSION: We have demonstrated that our new device overcomes water interference, allowing results to be obtained from stool samples that would otherwise be unsuitable for FE-1 analysis.
BACKGROUND:Human faecal elastase-1 (FE-1) is an established biochemical test for the investigation of pancreatic exocrine insufficiency. Conventional extraction methods for FE-1 analysis can give false-positive results with watery stools. This is a major limitation as patients investigated for pancreatic disease commonly produce such stools. We have developed an improved FE-1 test that overcomes water interference by measuring the enzyme in dried faeces. METHODS: A novel collection device for FE-1 analysis that involves drying and weighing the stool sample was developed in our laboratory and compared with a conventional wet method, E1 Quick-Prep (Schebo, Biotech AG, Germany). The concentration of faecal FE-1 was determined using a commercially available enzyme-linked immunosorbent assay method (Schebo). RESULTS:FE-1 values obtained using the new dry extraction procedure (mean 1777 microg/g dry stool) were higher when compared with the conventional wet analysis (mean 402 microg/g stool). A 1:2 dilution in water, mimicking a loose stool, was found to affect FE-1 results obtained using the conventional wet extraction procedure. The new dry extraction method gave consistent results when water content was varied in the original stool sample. CONCLUSION: We have demonstrated that our new device overcomes water interference, allowing results to be obtained from stool samples that would otherwise be unsuitable for FE-1 analysis.
Authors: Kirstin A Carswell; Royce P Vincent; Ajay P Belgaumkar; Roy A Sherwood; Stephanie A Amiel; Ameet G Patel; Carel W le Roux Journal: Obes Surg Date: 2014-05 Impact factor: 4.129